Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000652237 | SCV000774105 | likely benign | Tumor predisposition syndrome 3 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001731845 | SCV001982457 | likely benign | not provided | 2021-03-25 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001731845 | SCV005626189 | uncertain significance | not provided | 2024-10-21 | criteria provided, single submitter | clinical testing | The POT1 c.1007-8C>T variant has not been reported in individuals with POT1-related conditions in the published literature. It also has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant does not affect POT1 mRNA splicing. Based on the available information, we are unable to determine the clinical significance of this variant. |
Prevention |
RCV003918071 | SCV004727770 | likely benign | POT1-related disorder | 2022-06-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |